Vir Biotechnology, Inc. (NASDAQ:VIR) is a commercial-stage immunology company focused on infectious diseases. VIR has a portfolio of drug candidates, primarily at the Phase...
After the market closed on October 18th, shares of pure-play streaming giant Netflix (NASDAQ:NFLX) skyrocketed, rising around 13.7% in after-hours trading. This move came...